Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial

WINNIPEG, MB / ACCESS Newswire / September 28, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and …